ArticleJournal of hepatocellular carcinoma2021

A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by

Ahmed Omar Kaseb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.